ANI Pharmaceuticals Inc (ANIP)

Fixed asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	614,376	555,456	538,953	517,460	486,816	449,394	401,386	358,694	316,385	283,082	251,322	226,092	216,136	212,459	213,377	213,222	208,475	199,189	197,547	203,434
Property, plant and equipment	US$ in thousands	—	—	—	—	—	—	44,371	43,275	43,246	42,830	43,771	52,713	52,671	39,526	40,334	40,767	41,269	40,444	39,937	40,353
Fixed asset turnover		—	—	—	—	—	—	9.05	8.29	7.32	6.61	5.74	4.29	4.10	5.38	5.29	5.23	5.05	4.93	4.95	5.04

December 31, 2024 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $614,376K ÷ $—K
= —

The fixed asset turnover ratio measures a company's ability to generate sales from its fixed assets. A higher ratio indicates that the company is more efficient in utilizing its fixed assets to generate revenue.

Examining the data provided for ANI Pharmaceuticals Inc's fixed asset turnover, we observe a fluctuating trend over time. The ratio ranged from 4.10 to 9.05 from December 31, 2021, to June 30, 2023. This indicates varying efficiency in utilizing fixed assets during this period.

Notably, there was a significant increase in the fixed asset turnover ratio from 4.10 on December 31, 2021, to 9.05 on June 30, 2023, suggesting a substantial improvement in the company's ability to generate sales from its fixed assets during that period.

It should be highlighted that from September 30, 2023, onwards, the data is not available, represented by "—". This lack of data for later periods limits our ability to provide a comprehensive analysis of the company's fixed asset turnover over the entirety of the timeline.

In conclusion, the fixed asset turnover ratios for ANI Pharmaceuticals Inc showed variability over the observed period, with a notable improvement in efficiency between December 31, 2021, and June 30, 2023. Further insight and trend analysis would be required to assess the company's ongoing performance in terms of utilizing its fixed assets to generate sales.